FDA investigates Merck drug-suicide link AP via Yahoo! News Fri, 28 Mar 2008 3:17 AM PDT The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling Singulair and suicide. | Honduras: Cantaloupe Ban Criticized New York Times Thu, 27 Mar 2008 11:26 PM PDT Officials are denouncing a Food and Drug Administration decision asking American grocers to stop selling cantaloupe imported from a Honduran company because of links to a salmonella outbreak | U.S. to Study Drug for Suicide Links NYTimes.com via Yahoo! Finance Fri, 28 Mar 2008 9:40 AM PDT The Food and Drug Administration said Thursday that it was investigating a possible link between Merck’s best-selling drug Singulair and suicide. | FDA probes Merck drug, possible suicides AP via Yahoo! News Thu, 27 Mar 2008 8:08 PM PDT The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling Singulair and suicide. FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug. | F.D.A. Reviewing H.I.V. Drugs for Heart Risk New York Times Thu, 27 Mar 2008 7:25 PM PDT The Food and Drug Administration said that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack. | FDA Probes Merck Drug, Possible Suicides Washington Post Thu, 27 Mar 2008 8:47 PM PDT WASHINGTON -- The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling Singulair and suicide. FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and... | FDA Probing Allergy Drug Suicide Risks CBS News Fri, 28 Mar 2008 9:00 AM PDT The U.S. Food and Drug Administration said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken Merck's best-selling Singulair. | BioMimetic Up Despite FDA Note AP via Yahoo! Finance Fri, 28 Mar 2008 9:13 AM PDT Shares of BioMimetic Therapeutics Inc. are surging as Wall Street brushes off anxiety over Food and Drug Administration concerns linking a competitor's diabetic foot ulcer treatment to higher cancer risk. | FDA Probing Possible Link Between Asthma Drug and Suicide Risk HealthDay via Yahoo! News Thu, 27 Mar 2008 1:03 PM PDT THURSDAY, March 27 (HealthDay News) -- The U.S. Food and Drug Administration said Thursday it was investigating the possibility of an increased risk of mood changes and suicidal behavior among those who take the highly popular asthma drug Singulair. |
| |
|
No comments:
Post a Comment